Impact of microgravity on the fibrillization kinetics and structure of amyloid beta peptide

Hitendranath Napa Mallikarjuna1, Anagha Manohar1, Narendran Sekar1

  • 1Department of Applied Mechanics and Biomedical Engineering, Indian Institute of Technology Madras, Chennai, India. swathi.s@iitm.ac.in.

Chemical Communications (Cambridge, England)
|October 23, 2025
PubMed

Insights

Microgravity slows amyloid beta (Aβ) aggregation, forming less complex fibrils. This research explores protein misfolding risks for astronauts and Alzheimer

Area of Science:

  • Neuroscience
  • Biochemistry
  • Space Medicine

Background:

  • Amyloid beta (Aβ) peptides are linked to Alzheimer's disease (AD).
  • Protein misfolding and aggregation into fibrils are key pathological features of AD.
  • Understanding Aβ behavior in microgravity is crucial for long-term space mission health risks.

Purpose of the Study:

  • To investigate the impact of microgravity on amyloid beta (Aβ) aggregation kinetics and fibril morphology.
  • To assess the implications of altered Aβ aggregation in spaceflight for neurodegenerative disease risk.

Main Methods:

  • Studied the aggregation of Aβ(1-40) under simulated microgravity conditions.
  • Analyzed fibrillization kinetics and characterized the resulting fibril structures.

Main Results:

  • Microgravity significantly delayed the fibrillization kinetics of Aβ(1-40).
  • Fibrils formed in microgravity were more linear and less polymorphic.
  • Reduced parallel β-sheet content was observed in microgravity-induced fibrils.

Conclusions:

  • Microgravity fundamentally alters amyloid beta aggregation pathways.
  • Findings suggest microgravity could be a tool to study amyloid formation mechanisms.
  • Altered Aβ aggregation in space may have implications for astronaut neurodegenerative disease risk.